Abstract
Purpose
To compare the results of open radical prostatectomy (OP) and robotic prostatectomy (RP) for a single surgeon's experience of 219 radical prostatectomy cases.
Materials and Methods
Between June 2002 and June 2007, 133 patients underwent OP and between July 2005 and June 2007, 86 patients underwent RP. To compare the surgeon's experience-related differences, we divided the OP cases into 73 early cases (OP-I) and 60 late cases (OP-II), and the RP cases into 30 early cases (RP-I) and 56 late cases (RP-II). The clinical characteristics, perioperative results, and early clinical outcomes were evaluated.
Results
There were no significant differences in the preoperative characteristics between the four groups. For the RP cases, the mean estimated blood loss was decreased, a normal diet was started earlier, the mean duration of hospital stay and the mean duration of bladder catheterization was shorter than for the OP cases. The frequency of intraoperative complications significantly decreased in the RP-II group as compared to the RP-I group. Although there was no significant statistical difference in the positive surgical margin rates between the four groups, the rates were slightly decreased in the RP-II group. The recovery period of continence was shorter in the RP-II group than in the OP group and for patients 60 years or older, recovery of potency was also better in the RP-II group than the OP group.
Conclusions
Our results suggest that RP at the hands of an experienced surgeon may decrease the positive surgical margin rate to some degree. Additionally, performance of RP may lead to a shorter duration of bladder catheterization and hospital stay and a better recovery of continence and potency than obtainable by OP.
REFERENCES
1. Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982; 128:492–7.
2. Guillonneau B, el-Fettouh H, Baumert H, Cathelineau X, Doublet JD, Fromont G, et al. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. J Urol. 2003; 169:1261–6.
3. Bhayani SB, Pavlovich CP, Hsu TS, Sullivan W, Su LM. Prospective comparison of short-term convalescence: laparoscopic radical prostatectomy versus open radical retropubic prostatectomy. Urology. 2003; 61:612–6.
5. Hara I, Kawabata G, Miyake H, Nakamura I, Hara S, Okada H, et al. Comparison of quality of life following laparoscopic and open prostatectomy for prostate cancer. J Urol. 2003; 169:2045–8.
6. Jaffe J, Stakhovsky O, Cathelineau X, Barret E, Vallancien G, Rozet F. Surgical outcomes for men undergoing laparoscopic radical prostatectomy after transurethral resection of the prostate. J Urol. 2007; 178:483–7.
7. Touijer K, Guillonneau B. Laparoscopic radical prostatectomy: a critical analysis of surgical quality. Eur Urol. 2006; 49:625–32.
8. Menon M, Tewari A, Baize B, Guillonneau B, Vallancien G. Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: the Vattikuti Urology Institute experience. Urology. 2002; 60:864–8.
9. Nelson B, Kaufman M, Broughton G, Cookson MS, Chang SS, Herrell SD, et al. Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy. J Urol. 2007; 177:929–31.
10. Webster TM, Herrell SD, Chang SS, Cookson MS, Baumgartner RG, Anderson LW, et al. Robotic assisted laparoscopic radical prostatectomy versus retropubic radical prostatectomy: a prospective assessment of postoperative pain. J Urol. 2005; 174:912–4.
11. Tewari A, Srivasatava A, Menon M. A prospective comparison of radical retropubic and robot-assisted prostatectomy: experience in one institution. BJU Int. 2003; 92:205–10.
12. Rassweiler J, Seemann O, Schulze M, Teber D, Hatzinger M, Frede T. Laparoscopic versus open radical prostatectomy: a comparative study at a single institution. J Urol. 2003; 169:1689–93.
13. Salomon L, Levrel O, de la Taille A, Anastasiadis AG, Saint F, Zaki S, et al. Radical prostatectomy by the retropubic, perineal and laparoscopic approach: 12 years of experience in one center. Eur Urol. 2002; 42:104–10.
Table 1.
OP | RP | p-value | |||
---|---|---|---|---|---|
OP-I (n=73) | OP-II (n=60) | RP-I (n=30) | RP-II (n=56) | ||
Age (year) | 65.3±6.1 | 66.9±6.0 | 65.3±9.8 | 67.6±5.7 | 0.479∗ |
BMI (kg/m2) | 23.9±1.8 | 23.6±1.8 | 23.7±2.0 | 23.6±2.2 | 0.902∗ |
Preoperative PSA (ng/ml) | 21.1±20.6 | 55.2±237.0 | 9.9±6.4 | 21.3±33.5 | 0.370∗ |
Biopsy Gleason score (%) | 0.567† | ||||
≤6 | 30 (41) | 29 (48) | 20 (67) | 18 (32) | |
7 | 22 (30) | 17 (28) | 7 (23) | 24 (43) | |
≥8 | 21 (29) | 14 (23) | 3 (10) | 14 (25) | |
Clinical stage (%) | 0.391† | ||||
T1 | 46 (63) | 38 (63) | 26 (87) | 38 (68) | |
T2 | 11 (15) | 8 (13) | 3 (10) | 6 (11) | |
T3 | 16 (22) | 13 (22) | 0 (0) | 11 (19) | |
T4 | 0 (0) | 1 (2) | 1 (3) | 1 (2) |
Table 2.
OP | RP | p-value | |||
---|---|---|---|---|---|
OP-I (n=73) | OP-II (n=60) | RP-I (n=30) | RP-II (n=56) | ||
Prostatectomy Gleason score (%) | 0.281‡ | ||||
≤6 | 14 (19) | 16 (27) | 16 (53) | 15 (27) | |
7 | 36 (49) | 34 (57) | 10 (33) | 21 (37) | |
≥8 | 23 (32) | 10 (16) | 4 (13) | 20 (36) | |
NVB saving (%) | <0.001‡ | ||||
Bilateral | 24 (33) | 28 (47) | 5 (17) | 33 (59) | |
Unilateral | 16 (22) | 16 (27) | 2 (7) | 16 (29) | |
No saving | 33 (45) | 16 (27) | 23 (77) | 7 (13) | |
Pathologic stage (%) | 0.326‡ | ||||
pT0 | 1 (1) | 4 (7) | 1 (3) | 0 (0) | |
pT2 | 34 (47) | 27 (45) | 17 (57) | 35 (63) | |
pT3 | 32 (44) | 23 (38) | 11 (37) | 18 (32) | |
pT4 | 6 (8) | 6 (10) | 1 (3) | 3 (5) | |
Lymph node invasion | (%) 14 (19) | 5 (8) | 0 (0) | 4 (7) | 0.025‡ |
ECE (%) | 41 (56) | 31 (52) | 12 (40) | 20 (36) | 0.150§ |
Positive margin (%) | 32 (44) | 13 (22) | 8 (27) | 11 (20) | 0.007§ |
pT2 (n=113) | 9/34 (26) | 2/27 (7) | 3/17 (18) | 3/35 (9) | 0.254‡ |
pT3 (n=84) | 14/32 (44) | 8/23 (35) | 4/11 (36) | 5/18 (28) | 0.158‡ |
EBL (ml)∗ | 1,085.5±107.0 | 785.5±108.0 | 659.0±157.0 | 335.6±146.0 | <0.001† |
T∥ | a | b | c | d | |
Postop diet (days)∗ | 2.3±0.7 | 1.7±0.7 | 1.8±0.8 | 1.4±0.7 | <0.001† |
T∥ | a | b, c | b | c | |
Hospital stay (days)∗ | 8.9±3.7 | 6.6±3.7 | 5.1±2.3 | 3.5±1.4 | <0.001† |
T∥ | a | b | c | d | |
Catheterization (days)∗ | 14.9±1.7 | 13.3±1.7 | 11.8±1.9 | 9.5±1.5 | <0.001† |
T∥ | a | b | c | d | |
Complication (%) | 7 (10) | 4 (7) | 5 (17) | 1 (2) | 0.075‡ |
Major | |||||
Rectal injury | 2 (3) | 1 (2) | 1 (3) | 1 (2) | |
Infected hematom | ma 1 (1) | 0 (0) | 0 (0) | 0 (0) | |
Minor | |||||
Retention | 1 (1) | 0 (0) | 1 (3) | 0 (0) | |
Anastomotic leak | age 1 (1) | 1 (2) | 1 (3) | 0 (0) | |
Lymphocele | 0 (0) | 1 (2) | 0 (0) | 0 (0) | |
Ileus | 2 (3) | 1 (2) | 2 (7) | 0 (0) |
Table 3.
OP | RP | p-value | |||
---|---|---|---|---|---|
OP-I (n=73) | OP-II (n=60) | RP-I (n=30) | RP-II (n=56) | ||
Continence (%) | |||||
Postoperative 1 month | 14 (19.2) | 27 (45.0) | 15 (50.0) | 29 (51.8) | <0.001∗ |
Postoperative 3 month | 42 (57.5) | 48 (80.0) | 25 (83.3) | 50 (89.3) | <0.001∗ |
Postoperative 6 month | 60 (82.2) | 53 (88.3) | 27 (90.0) | 54 (96.4) | 0.083∗ |
Table 4.
≤60 years | >60 years | |
---|---|---|
OP (%) (n=133) | 11/23 (48) | 38/110 (35)† |
OP-I (n=73) | ||
Bilateral NVB saving (n=24) | 5/5 (100) | 10/19 (53)∗ |
Unilateral NVB saving (n=16) | 1/3 (33) | 5/13 (39) |
No NVB saving (n=33) | 0/7 (0) | 0/26 (0) |
OP-II (n=60) | ||
Bilateral NVB saving (n=28) | 4/4 (100) | 16/24 (67)∗ |
Unilateral NVB saving (n=16) | 1/2 (50) | 7/14 (50) |
No NVB saving (16) | 0/2 (0) | 0/14 (0) |
RP (%) (n=86) | 10/17 (59) | 36/69 (52)† |
RP-I (n=30) | ||
Bilateral NVB saving (n=5) | 1/1 (100) | 3/4 (75)∗ |
Unilateral NVB saving (n=2) | 1/1 (100) | 0/1 (0) |
No NVB saving (n=23) | 1/7 (14) | 0/16 (0) |
RP-II (n=56) | ||
Bilateral NVB saving (n=33) | 5/5 (100) | 25/28 (89)∗ |
Unilateral NVB saving (16) | 2/2 (100) | 8/14 (57) |
No NVB saving (n=7) | 0/1 (0) | 0/6 (0) |